Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy. [electronic resource]
Producer: 20180806Description: e39-e42 p. digitalISSN:- 1592-8721
- Adolescent
- Antineoplastic Agents -- therapeutic use
- Child
- Child, Preschool
- Drug Administration Schedule
- Female
- Fusion Proteins, bcr-abl -- antagonists & inhibitors
- Gene Expression
- Germany
- Humans
- Imatinib Mesylate -- therapeutic use
- Infant
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Protein Kinase Inhibitors -- therapeutic use
- RNA, Messenger -- antagonists & inhibitors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.